New Data Reveals Escalating Anxiety Among Canadians Amid Political and Economic Turmoil - GreenShield Responds with Free Therapy Initiative to Support All Canadians
TORONTO, March 27, 2025 /CNW/ - As Canada-U.S. trade tensions escalate and the cost of living continues to rise, new data reveals nearly half of Canadians are experiencing heightened anxiety, with tariffs quickly emerging as one of the top drivers.
Last month, GreenShield—a proudly Canadian-owned and operated non-profit health and benefits company—partnered with Mental Health Research Canada (MHRC) to identify key trends and gaps in care for Canadians amidst growing economic and political uncertainty. The data revealed a significant spike in anxiety over the past month, with the rising cost of living and political tensions with the U.S. reported among the top stressors for Canadians.According to this new data:
In 2024 there was a declining trend in the number of Canadians reporting negative mental health impacts due to economic conditions; however, the start of 2025 marked a sharp spike, with:
42% now reporting the economic downturn is negatively affecting their mental health, and
39% worrying about the possibility of not being able to pay their bills.
Nearly 50% of Canadians reported increased anxiety in the past month, with concerns highest among lower-income households and women.
Almost 40% of Canadians now cite political unpredictability and tensions with the U.S. as a source of heightened anxiety – second only to concerns over the rising cost of living (52%).
Anxiety is highest in Ontario and British Columbia.
Despite growing demand for mental health support, cost and accessibility continue to be major barriers to care – putting therapy further out of reach for those who need it most. As a purpose-driven non-profit and the country's fastest-growing mental health provider, GreenShield is committed to supporting the mental health of Canadians during challenging times. To help break down these barriers, the company will offer two months of free therapy to Canadians looking to start their mental health journey. The offer includes two sessions with a licensed therapist and an unlimited subscription to digital cognitive behavioural therapy (CBT), with no membership or commitment required.
"Time and again, we've seen the deep connection between economic uncertainty and declines in mental well-being. As a proudly Canadian and purpose driven company, we're committed to reducing barriers to care for all Canadians as we collectively navigate this challenging time," said Zahid Salman, President and CEO of GreenShield. "This is about Canadians helping Canadians. Mental health is not just an individual issue – it's a national one. Ensuring Canadians have access to support during tough times strengthens the entire country."
GreenShield's initiative builds on past lessons from economic downturns, including the 2008 financial crisis and the COVID-19 pandemic, both of which saw surges in mental health challenges. These moments have reinforced a critical truth that during times of financial uncertainty, access to mental health support is more important than ever, yet too often remains out of reach for those who need it.
"Our data confirms that today's political and economic climate is fueling widespread stress and anxiety," said Akela Peoples, CEO of MHRC. "Failing to address the mental health toll of this instability could have long-term consequences for all of us as a country. We're proud to be sharing insights that can help Canadians build better solutions and we applaud GreenShield's impressive leadership in offering free support to all Canadians."
As a non-profit, GreenShield operates without short-term profit-driven shareholders, enabling the company to prioritize people and purpose over profits. GreenShield is committed to reinvesting its excess earnings to directly support the health and well-being of underserved communities. Through GreenShield Cares, the company has committed $75 million to improve the health of over one million Canadians by the end of this year, with a focus on mental health, essential medicines, and chronic disease management. By providing Canadians with a risk-free opportunity to try therapy – at no cost – with an inclusive network of therapists, GreenShield is helping to further reduce barriers to care for equity-seeking Canadians and advancing its mission of Better Health for All. Canadians can access GreenShield's free mental health offer from March 28th until May 28th, 2025 through GreenShield's website.
Research Methodology:
National Poll 23
MHRC's national polling is part of a multi-year effort to track the mental health challenges of COVID-19 and beyond. Since March 2020, the goal of MHRC's polling has been to capture Canadians' reported perception of their level of anxiety and depression, and to identify and evaluate the factors that influence mental well-being. Methodology: The online survey was conducted among a sample of 4,050 adult Canadians from Feb 4-24, 2025. This was the twenty-third poll of this study. Results between the polls are compared where applicable. This report focuses solely on the overall measures of mental health as well as the impact of the current economic conditions. While total results include the additional 4000 BC sample, these national results have been weighted by the most current census data in terms of gender, age, & region to ensure the total sample is representative of the population as a whole.
Omnibus Survey
A national one-time survey deployed to understand Canadians' experience with anxiety as it relates to current economic and political stressors.
Methodology: The survey was conducted with 1,500 adults in Canada from February 20 - 25, 2025. A random sample of panelists were invited to complete the survey from a set of partner panels based on the Lucid exchange platform. These partners are typically double opt -in survey panels, blended to manage out potential skews in the data from a single source. The margin of error for a comparable probability -based random sample of the same size is +/ - 2.53%, 19 times out of 20. The data were weighted according to census data to ensure that the sample matched Canada's population according to age, gender, educational attainment, and region. Totals may not add up to 100 due to rounding.
About GreenShield
As Canada's only national non-profit health and benefits company, GreenShield believes health care is a right, not a privilege. We're dedicated to improving health outcomes, driving systemic change, and building a future where every Canadian can reach their full health potential.
We are revolutionizing the health and benefits experience with coverage and care in one place. Through our unique integrated payer-provider ("payvider") model, offering insurance, administering benefits and paying claims as a 'payer' while offering health services such as mental health, pharmacy, telemedicine and chronic disease management as a 'provider'.
As a non-profit social enterprise, we don't have shareholders, which allows us to prioritize and reinvest our excess earnings to directly support underserved communities. Through GreenShield Cares, we've committed $75 million to improve the health of over one million Canadians by the end of 2025, focusing on mental health, essential medicines, and chronic disease management. Our scalable initiatives deliver meaningful change in pursuit of Better Health for All.
GreenShield is proud to be recognized as one of Canada's Most Admired Corporate Cultures, a leading Imagine Canada Caring Company, and named on the Fortune's Change the World list.
About Mental Health Research Canada
Mental Health Research Canada (MHRC) is a national charity that serves to advance mental health through studentships, granting, data collection/analysis and strategic initiatives. As a leading mental health organization in Canada, we are dedicated to improving the lives of all Canadians by advancing mental health knowledge in unique ways—notably by leading, seeding and influencing to create better mental health systems. One example of our work is funded by Health Canada to monitor and report on the mental health of Canadians. We collect population data, analyze and report on it to governments and stakeholders nationally to support data informed decision-making on what people need and how our services are performing. Mental health systems and services cannot improve without research – research is an investment in the future.
SOURCE GreenShield
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2025/27/c0258.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
an hour ago
- Indianapolis Star
Store cookies being recalled for possible wood contamination. What to know
A sweet treat sold in Indiana and other U.S. states is being recalled. A Canadian manufacturer is recalling hundreds of cases of sugar cookies sold at Target due to potential contamination of a "foreign material," according to a Food and Drug Administration notice. The voluntary recall was initiated on July 22 and categorized as a Class II recall on Aug. 4. The 803 recalled cases were distributed across 20 states and Washington, D.C. The Favorite Day Bakery Frosted Sugar Cookies, 10 count, were distributed by Target and produced in Canada. The recalled cases have a net weight of 13.5 oz (383g), a unique product code of 85239-41250 3 and a lot code of 25195. The FDA says the cookies' Best By Date can vary, as they were applied by retailers after being removed from the freezer. The cookies were shipped to three distribution centers in Connecticut, Maryland and Ohio and sold at retail stores in the following states: The cookies are being recalled due to a possible contamination of wood. The administration defines a Class II recall as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." This is the second most serious type of recall, just under a Class I recall, according to the administration. The FDA recommends that consumers who purchased recalled products do the following:
Yahoo
2 hours ago
- Yahoo
Sugar cookies sold in 20 states recalled for potential wood contamination: See map
Sugar cookies sold in 20 states recalled for potential wood contamination: See map Hundreds of cases of sugar cookies sold at Target are being recalled for potential contamination by a "foreign material," according to a notice posted to the Food and Drug Administration's website. The voluntary recall for the Favorite Day Bakery Frosted Sugar Cookies was issued on July 22 by Give and Go Prepared Foods Corp. in Canada, according to the FDA. Favorite Day is a private label brand sold at Target. In total, 803 cases are being recalled due to the potential foreign contamination. The cookies, which could potentially contain wood, were distributed across 20 different states and Washington, D.C., the notice stated. The recall is classified as a Class II recall, meaning the product "may cause temporary or medically reversible adverse health consequences," according to the FDA. A press release was not issued for the recall, but as of Sunday, Aug. 10, the recall is ongoing. Target did not immediately respond to a request for comment from USA TODAY on Aug. 10. Where were the recalled sugar cookies sold? The cookies were sold in the following states and districts: Connecticut District of Columbia Delaware Illinois Indiana Kentucky Massachusetts Maryland Maine Michigan Montana North Carolina New Hampshire New Jersey New York Ohio Pennsylvania Rhode Island Tennessee Virginia Vermont How to tell if you purchased the recalled product The recalled cookies, Favorite Day Bakery Frosted Sugar Cookies, 10 count, were distributed by Target and produced in Canada. The cookies are a part of Lot 25195, with the UPC number 85239-41250 3. The packs of cookies have varying Best By Dates, as that is determined by when the retailer removed the cookies from the freezers, according to the notice. Julia is a trending reporter for USA TODAY. Connect with her on LinkedIn, X, Instagram and TikTok: @juliamariegz, or email her at jgomez@ This article originally appeared on USA TODAY: Favorite Day sugar cookies sold at Target in 20 states recalled Solve the daily Crossword
Yahoo
2 hours ago
- Yahoo
Cosmetic Surgery Market Size to Reach USD 83.34 Billion by 2034, Says Towards Healthcare Study
The global cosmetic surgery market is valued at USD 59.17 billion in 2025 and is projected to reach approximately USD 83.34 billion by 2034, expanding at a CAGR of 3.84% over the forecast period. Ottawa, Aug. 11, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global cosmetic surgery market size was valued at USD 56.98 billion in 2024 and is projected to reach approximately USD 83.34 billion by 2034, growing at a CAGR of 3.84% between 2024 and 2034. The growth of the market is driven by the growing demand for aesthetic enhancements, and demand for flawless appearance fuels the growth of the market, with enhanced and improved technology driving the growth of the market. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America dominated the global cosmetic surgery market in 2024. Europe is anticipated to grow at the highest CAGR in the market during the forecast period. By procedure, the surgical procedures segment held a dominant presence in the market in 2024. By procedures, the non-surgical procedures segment is anticipated to grow at the fastest rate in the market during the studied years. By gender, the female segment was dominant in the market in 2024. By gender, the male segment is predicted to grow at the highest CAGR in the market. By age group, the 35 to 50-year segment held the highest share of the market in 2024. By age group, the 19 to 34-year segment is estimated to grow at the fastest CAGR during the predicted timeframe. By provider, the hospitals & specialty clinics segment held the largest share of the market. By provider, the spas & cosmetic surgery centers segment is projected to grow at the fastest rate in the cosmetic surgery market during the forecast period. What is the Growth Potential Responsible for the Growth of the Cosmetic Surgery Market? Cosmetic surgery involves medical methods to improve or enhance a person's appearance, using both surgical and non-surgical techniques. Usually performed on healthy areas for aesthetic reasons rather than medical or reconstructive needs, the market is rapidly expanding. This growth is driven by increasing beauty awareness, heavily influenced by social media and celebrities, which boosts demand for cosmetic enhancements. Advances in technology have made procedures safer, less invasive, and more affordable, attracting more participants. Additionally, rising disposable incomes and better access to qualified professionals encourage more people to pursue cosmetic treatments. The pursuit of a youthful look and greater self-confidence significantly contributes to the market's continuous growth across different age groups and regions. You can place an order or ask any questions, please feel free to contact us at sales@ What are the Growing Trends Associated with the Cosmetic Surgery Market? Rising Demand for Cosmetic Procedures: The growth of the cosmetic surgery market due to rising demand increases the awareness and adoption, fueling growth. Technological Advancements: The advanced technology demanded by consumers for surgical processing and for enhancing the appeal drives the growth. Minimally Invasive Procedures: Demand and adoption of minimally invasive therapy and surgery for quick recovery and enhancement of the procedure fuel the growth. Natural-Looking Enhancements: The growing demand from consumers for enhanced and natural-looking results increases adoption, fueling the growth of the market. What is the Growing Challenge in the Cosmetic Surgery Market? The key challenge that hinders the growth of the market is the high cost and limited access, which in turn makes them inaccessible to a large population, limiting the growth of the market. The safety concerns and complications associated with the risks of infections, nerve damage, and scarring also decrease the adoption, limiting the growth. Other key challenges are the social and ethical considerations, competition, and regulatory hurdles that hinder the growth and expansion of the market. Regional Analysis How Did North America Dominate the Cosmetic Surgery Market in 2024? North America dominated the global market in 2024, due to its advanced healthcare infrastructure, cutting-edge cosmetic technologies, and experienced, board-certified surgeons. The region's rising demand for both invasive and non-invasive procedures is driven by cultural acceptance and a focus on personal aesthetics. Additionally, North America is a key destination for medical tourism, attracting patients from abroad for treatments, which boosts its market growth. In 2024, Americans underwent roughly 1.6 million surgical cosmetic procedures and 28.5 million minimally invasive treatments. Top surgeries: liposuction (~349,728), breast augmentation (~306,196), tummy tuck (~171,064), breast lift (~153,616), eyelid surgery (~120,755). Top injectables: neuromodulators (~9.88 million) and HA fillers (~5.33 million). In Canada, cosmetic surgery trends reflect increasing body positivity coupled with personal enhancement. Influences include American media, aging demographics seeking rejuvenation, and remote work enabling discrete recoveries. Accessibility via medical tourism and financing plans also play a role. Natural-looking results and non-invasive options are particularly favored among younger generations. What Caused Europe to Experience the Fastest Growth in the Cosmetic Surgery Market in the Forecast Period? Europe is anticipated to grow at the highest CAGR in the market during the forecast period. Innovations in minimally invasive procedures have improved safety and appeal. The aging population is also increasing the need for anti-aging treatments like Botox and facelifts. Furthermore, cultural acceptance of cosmetic procedures, strengthened by media and celebrity influence, encourages more individuals to seek aesthetic enhancements. Europe's strong position in medical tourism, especially in countries like Turkey and Poland, further drives its rapid market expansion. The cosmetic surgery market in Germany is influenced by a strong culture of self-care, wellness, and discreet enhancement. Many seek natural, balanced results, often for aging concerns rather than dramatic changes. High medical standards, privacy, and a stigma-free attitude toward aging gracefully motivate patients. Men are increasingly exploring facial and body procedures. In the UK, cosmetic surgery is fueled by social media, celebrity culture, and rising self-image concerns. Reality TV, influencers, and post-pandemic self-focus drive interest. Patients seek subtle improvements, often opting for non-surgical treatments first. Accessibility through private clinics and financing options makes aesthetic enhancements more attainable across age groups. Get the latest insights on healthcare industry segmentation with our Annual Membership: Segmental Insights By Procedures The surgical procedures segment held a dominant presence in the cosmetic surgery market in 2024, driven by a consistent preference for long-lasting results and advancements in minimally invasive techniques. Procedures such as breast augmentation, liposuction, rhinoplasty, and abdominoplasty are popular due to their ability to provide permanent aesthetic improvements that often surpass non-surgical options. Innovations like robotic-assisted surgeries have improved recovery times and reduced scarring, making these procedures more attractive. The presence of skilled surgeons and specialized clinics has further strengthened patient confidence, supporting the ongoing growth and market dominance of cosmetic surgery. The non-surgical procedures segment is anticipated to grow at the fastest rate in the market during the studied years due to their minimally invasive nature, lower costs, and shorter recovery times. Treatments such as Botox, dermal fillers, and laser therapies are increasingly favored for delivering subtle, natural results without surgery. The rising demand for aesthetic enhancements with minimal downtime and discomfort is propelling this trend, making non-surgical options more appealing and accessible to a wider audience. By Gender The female segment was dominant in the market in 2024, driven by cultural and societal pressures emphasizing beauty standards for women. The influence of social media, celebrity culture, and trends like the 'Instagram face' has encouraged more women to undergo procedures. Advances in technology have made treatments safer and more accessible, especially non-invasive options like Botox and fillers. Reduced stigma and easier financing have also contributed to this growth, with women increasingly seeking natural-looking enhancements aligned with confidence and modern beauty ideals. The male segment is predicted to grow at the highest CAGR in the market, as shifting perceptions of masculinity encourage men to pursue procedures such as liposuction, rhinoplasty, and Botox. The influence of social media and celebrities has helped normalize cosmetic enhancements among men. Additionally, rising obesity rates and greater access to minimally invasive technologies have boosted demand for body contouring and anti-aging treatments. These factors collectively drive rapid growth in the male cosmetic surgery market. By Age Group The 35 to 50 years segment held the highest share of the market in 2024, motivated by the desire to combat early signs of aging with treatments like Botox, fillers, and body contouring. This age group generally has greater financial stability, enabling investment in aesthetic improvements. Social and professional pressures to maintain a youthful appearance, coupled with technological advances, have made cosmetic procedures increasingly appealing and accessible. The 19 to 34 years segment is estimated to grow at the fastest CAGR during the predicted timeframe, driven by changing attitudes toward beauty and self-care. Younger consumers are more inclined toward non-invasive procedures like dermal fillers, laser treatments, and skin rejuvenation. The rise of influencer culture and online beauty trends has mainstreamed cosmetic enhancements. This demographic is also more willing to spend on personal appearance, prioritizing self-expression and confidence, which fuels market growth. By Provider The hospitals & specialty clinics segment held the largest share of the cosmetic surgery market in 2024, due to their advanced infrastructure, broad service range, and highly qualified staff. These facilities offer the latest technologies and adhere to strict safety standards, making them the preferred choice for both surgical and non-surgical procedures, which increases the demand. Their reputation for quality care and regulatory compliance has reinforced their leading position, which supports the growth and expansion of the market globally. The spas & cosmetic surgery centers segment is projected to grow at the fastest rate in the cosmetic surgery market during the forecast period. The growth of the market is driven by the rising focus on non-invasive and minimally invasive treatments like Botox, fillers, and laser therapies. These centers combine medical care with a relaxing atmosphere, attracting clients seeking quick results with minimal downtime. The popularity of aesthetic treatments, driven by social media, self-care trends, and wellness tourism, has significantly contributed to the rising demand in this segment, supporting the growth and expansion of the market. Become a valued research partner with us - Recent Developments in the Cosmetic Surgery Market In April 2025, Bliss Aesthetics announced a $17.5 million seed funding round. The company provides an AI-based digital platform that helps in connecting patients with board-certified plastic surgeons. In August 2024, AirSculpt Technologies, Inc. opened a new facility in Columbus, equipped with two operating rooms to allow multiple procedures at the same time. The center also expanded its treatment options by including the advanced AirSculpt skin tightening procedure, further enhancing its range of cosmetic services. Top Companies and Their Offerings to the Cosmetic Surgery Market Company Contributions & Offerings Evolus Inc. Specializes in aesthetic neurotoxins. Its flagship product, Jeuveau, is a Botox competitor focused purely on aesthetic use, marketed as a modern, millennial-friendly brand. Revance Offers Daxxify, a long-lasting botulinum toxin, and the RHA Collection of dermal fillers. Focuses on innovation, premium branding, and practitioner relationships. Galderma Known for Dysport (neurotoxin) and Restylane (filler line). It offers a wide portfolio in injectables, skincare (Cetaphil), and prescription dermatology, spanning all ages. AbbVie Owns Allergan Aesthetics, maker of Botox and Juvederm. It dominates the global injectable market and offers CoolSculpting and breast implants through Natrelle. Cynosure Develops energy-based devices for body contouring, hair removal, and skin revitalization, including SculpSure, PicoSure, and TempSure. Lumenis Offers advanced laser and IPL systems for skin resurfacing, hair removal, and gynecological aesthetics. Known for M22 and NuEra Tight platforms. Solta Medical Provides non-invasive aesthetic solutions such as Thermage (skin tightening), Fraxel (laser resurfacing), and Clear + Brilliant. Alma Lasers Offers devices for hair removal, tattoo removal, skin tightening, and body contouring. Known for Harmony XL Pro, Soprano, and Accent Prime. Syneron Candela Delivers aesthetic energy devices including CO₂RE, GentleMax Pro, and Vbeam. Strong in dermatology, vascular treatments, and pigment correction across global markets. Cosmetic Surgery Market Top Key Players Evolus Inc. Revance Galderma AbbVie Cynosure Lumenis Solta Medical Alma Laser Syneron Candela Browse More Insights of Towards Healthcare: The South Korea cosmetic surgery and procedures market is valued at USD 2.47 billion in 2024, increasing to USD 2.90 billion in 2025, and is expected to reach USD 12.14 billion by 2034, registering a robust CAGR of 17.23% from 2025 to 2034. The global skincare market is valued at USD 115.69 billion in 2024, growing to USD 123.64 billion in 2025, and projected to reach USD 224.83 billion by 2034, expanding at a CAGR of 6.87% during 2025–2034. The global skin repair market stands at USD 85.00 billion in 2024, rising to USD 90.58 billion in 2025, and is anticipated to reach USD 160.46 billion by 2034, growing at a CAGR of 6.56% between 2025 and 2034. The global personalized skin care products market is valued at USD 30.63 billion in 2024, expanding to USD 33.09 billion in 2025, and is expected to reach USD 66.37 billion by 2034, advancing at a CAGR of 8.04% from 2025 to 2034. The global skin repair dressing market was valued at USD 8.06 billion in 2023 and is projected to reach USD 16.45 billion by 2034, growing at a CAGR of 6.7% from 2024 to 2034. The global specialty medical chairs market is valued at USD 5.12 billion in 2025 and is expected to reach USD 9.77 billion by 2034, expanding at a CAGR of 7.43% during the forecast period. The global home healthcare market is projected to grow from USD 226.92 billion in 2025 to USD 476.80 billion by 2034, at a CAGR of 8.6% between 2025 and 2034. The global biopreservation market is valued at USD 3.65 billion in 2024, increasing to USD 4.68 billion in 2025, and is expected to surge to USD 44.51 billion by 2034, registering an impressive CAGR of 28.34% from 2025 to 2034. The global medical aesthetics market was valued at over USD 6.25 billion in 2024 and is anticipated to reach more than USD 8.64 billion by 2034, growing at a CAGR of 3.29% between 2025 and 2034. The global advanced liver cancer market is valued at USD 2.65 billion in 2024, growing to USD 2.97 billion in 2025, and is projected to reach USD 8.20 billion by 2034, expanding at a CAGR of 11.94% from 2025 to 2034. Segments Covered in The Report By Procedure Surgical Procedures Breast Augmentation Liposuction Eyelid Surgery Abdominoplasty Rhinoplasty Others Non-Surgical Procedures Botulinum Toxin Hyaluronic Acid Hair Removal Non-surgical Fat Reduction Photo Rejuvenation Others By Gender Female Male By Age Group 18 Years and Younger 19 to 34 Years 35 to 50 Years 51 to 64 Years 65 Years & Above By Provider Hospitals & Specialty Clinics Spas & Cosmetic Surgery Centers By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Immediate Delivery Available | Buy This Premium Research @ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway Access the Dashboard: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | InstagramError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
